BioCentury
ARTICLE | Company News

PharmAthene other news

August 13, 2012 7:00 AM UTC

PharmAthene said the U.S. Department of Defense exercised an option to provide up to $2.5 million in funding. The money will be used to develop a mammalian cell-based advanced expression manufacturing...